NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.


 
Letter to FDA Director on Medication Access
02/22/2021
Letter to FDA Center for Drug Evaluation and Research Director Choe, urging the FDA to commit to increased efficiency of generic reviews and greater attention to complex generics.
Comments to HHS Secretary on Medicaid
02/19/2021
Regulatory comments to HHS Acting Secretary Cochran, expressing support for Washington State’s request to extend a Medicaid demonstration program with an Institute for Mental Disease (IMD) waiver component.
Letter to Congressional Leadership on COVID-19 & Health Coverage
02/18/2021
Letter to Congressional Leadership, expressing support for the American Rescue Plan, specifically the health coverage provisions.
Letter to CMS Administrator on Child and Adolescent Mental Health & Medicaid
02/16/2021
Letter to CMS Acting Administrator Richter, urging the Centers for Medicare and Medicaid Services (CMS) to work directly with states and stakeholders to update the Medicaid School Health Technical Assistance Guide and Administrative Claiming Guide.
Letter to Treasury Secretary on COVID-19 & Social Supports
02/16/2021
Letter to Treasury Secretary Yellen, expressing support for additional outreach, resources, and support targeting all non-tax filers who have not yet received their economic impact payments.
Letter to HHS Secretary on Medicare & Medication Access
02/15/2021
Letter to Secretary-Designee Becerra, expressing opposition to recent change allowing health insurance plans to severely limit Medicare Part D drug coverage.
Letter to Congressional Leadership on COVID-19 & Child and Adolescent Mental Health
02/12/2021
Letter to Congressional Leadership, urge inclusion of an additional $16 million to expand the Pediatric Mental Health Care Access Program at the Health Resources and Services Administration (HRSA) to all states, D.C., and the territories.
Letter to HHS Secretary on Treatment Innovation
02/12/2021
Letter to HHS Acting Secretary Cochran, urging the withdrawal of the proposed rule on extramural research involving human fetal tissue.
Statement for the Record on Medicaid & COVID-19
02/11/2021
Statement for the Record, urging the House Energy and Commerce Committee to advance provisions that would help support the health and wellbeing of the American public while also slowing the spread of the COVID-19 virus.
Statement for the Record on COVID-19 & Health Coverage
02/10/2021
Statement for the Record, urging the House Ways and Means Committee to advance legislation that would help support the health and wellbeing of the American public while also slowing the spread of the COVID-19 virus.
Displaying results 91-100 (of 121)
 <  4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13  >